文献速递血栓与止血

成人原发免疫性血小板减少症患者血栓住院风险因素:法国全国队列研究

Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
PubMed 文献 · Br J Haematol · 2021-08-12

多变量Cox回归显示,脾切除、糖皮质激素、血小板生成素受体激动剂(TPO-RAs)和静脉免疫球蛋白(IVIg)暴露与VT住院风险升高相关;脾切除、IVIg和TPO-RAs暴露与AT住院风险升高相关;利妥昔单抗未增加风险。

要点

  • TPO-RAs和IVIg暴露与VT及AT住院风险均升高相关。

核心结论

  • 成人ITP患者中,脾切除、糖皮质激素、TPO-RAs和IVIg暴露与血栓住院风险升高相关。
  • 利妥昔单抗未与血栓住院风险增加相关。

研究设计与样本

  • 结局为首次静脉血栓(VT)或动脉血栓(AT)住院,采用多变量Cox回归分析。

主要发现

  • 利妥昔单抗未与血栓住院风险增加相关。

临床怎么用

  • 上述风险因素有助于评估成人ITP患者血栓风险并指导治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to assess the risk factors of venous thrombosis (VT) and arterial thrombosis (AT) in adults with primary immune thrombocytopenia (ITP), particularly in relation to treatments. The population comprised all incident primary ITP adults in France between 2009 and 2017 (FAITH cohort; NCT03429660) built in the national health database. Outcomes were the first hospitalisation for VT and AT. Multivariable Cox regression models included baseline risk factors, time-varying exposure to ITP drugs, splenectomy and to cardiovascular drugs. The cohort included 10 039 patients. A higher risk of hospitalisation for VT was observed with older age, history of VT, history of cancer, splenectomy [hazard ratio (HR) 3·23, 95% confidence interval (CI) 2·26-4·61], exposure to corticosteroids (HR 3·55, 95% CI 2·74-4·58), thrombopoietin-receptor agonists (TPO-RAs; HR 2·28, 95% CI 1·59-3·26) and intravenous immunoglobulin (IVIg; HR 2·10, 95% CI 1·43-3·06). A higher risk of hospitalisation for AT was observed with older age, male sex, a history of cardiovascular disease, splenectomy (HR 1·50, 95% CI 1·12-2·03), exposure to IVIg (HR 1·85, 95% CI 1·36-2·52) and TPO-RAs (HR 1·64, 95% CI 1·26-2·13). Rituximab was not associated with an increased risk. These findings help to estimate the risk of thrombosis in adult patients with ITP and to select treatment.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Lafaurie M, Maquet J, Baricault B, et al. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study. Br J Haematol. 2021. PMID: 34386974. doi:10.1111/bjh.17709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。